Phibro Animal Health Earnings Review: Q2 Summary
Benzinga Insights 9 months ago
Earnings
Phibro Animal Health (NASDAQ:PAHC) reported its Q2 earnings results on Wednesday, February 4, 2026 at 04:25 PM.
Here's what investors need to know about the announcement.
Earnings
Phibro Animal Health beat estimated earnings by 27.94%, reporting an EPS of $0.87 versus an estimate of $0.68.
Revenue was up $64.60 million from the same period last year.
Performance in Previous Earnings
The company beat on EPS by $0.13 in the last quarter, resulting in a 4.59% increase share price change the following day.
Here's a look at Phibro Animal Health's past performance:
| Quarter | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|
| EPS Estimate | 0.60 | 0.52 | 0.53 | 0.45 |
| EPS Actual | 0.73 | 0.57 | 0.63 | 0.54 |
| Revenue Estimate | 349.13M | 361.80M | 352.41M | 316.53M |
| Revenue Actual | 363.90M | 378.70M | 347.80M | 309.30M |
To track all earnings releases for Phibro Animal Health visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
